
The pharmaceutical industry is a state of perpetual change with new types of research, the development of generic medicines and medical instruments. The legal context is becoming increasingly rigorous in order to keep pace. Technological changes mean that contamination control becomes more and more important and special installations are required for every process.
The manufacture of pharmaceutical products must be carried out under controlled environment conditions. The selection of materials and their shapes, the cleanliness, sealing and cleanability of the Clean Room envelope are essential to prevent any bacteriological contamination, to comply with Good Pharmaceutical Practices and guarantee quality.
DAGARD Clean Rooms are designed to meet all the conditions for pharmaceutical environments. The airtight enclosure causes no contamination that could downgrade products, it can be easily maintained in the state of cleanliness aligned to the required classification. The teams in charge of design, coordination and assembly are approved and experienced personnel.
| NF S ISO 14644 | ISO 4 | ISO 5 | ISO 6 | ISO 7 | ISO 8 | ISO 9 |
| Good Manufacturing Practices | A - B | C | D | |||
| FS 209 E | 10 | 100 | 1 000 | 10 000 | 100 000 | 1 000 000 |
| Research laboratory | ||||||
| Pharmaceutical products and active principles | ||||||
| Weighing | ||||||
| Packing units | ||||||
| Dagard line | » Ultra Clean line | |||||
| » Controlled Environment line | ||||||

Boiron, Bristol Myers Squibb, Famar, Glaxo Smith Kline, Merial, Novartis, Pfizer, Roche,Sanofi Aventis, Sigma Pharmaceuticals, ...